May 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 12.91 14.31 14.10
(-22.1 pct) (+9.2 pct)
Operating loss 316 mln 226 mln 160 mln
(-88.6 pct)
Recurring loss 292 mln 250 mln 190 mln
(-87.3 pct)
Net
Net loss 269 mln 216 mln 130 mln
(-83.5 pct)
EPS loss 71.14 yen 57.23 yen 34.38 yen
Ann Div 40.00 yen 40.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T